title: HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1.
abstract: Targeting dendritic cell (DC) functions such as migration is a pivotal mechanism used by HIV-1 to disseminate within the host. The HIV-1 envelope protein is the most important of the virally encoded proteins that exploits the migratory capacity of DCs. In the present study, we elucidated the signaling machinery involved in migration of immature DCs (iDCs) in response to HIV-1 envelope protein. We observed that M-tropic HIV-1 glycoprotein 120 (gp120) induces phosphorylation of the nonreceptor tyrosine kinase, Pyk2. Inhibition of Pyk2 activity using a pharmacologic inhibitor, kinase-inactive Pyk2 mutant, and Pyk2-specific small interfering RNA blocked gp120-induced chemotaxis, confirming the role of Pyk2 in iDC migration. In addition, we also illustrated the importance of Pyk2 in iDC migration induced by virion-associated envelope protein, using aldithriol-2-inactivated M-tropic HIV-1 virus. Further analysis of the downstream signaling mechanisms involved in gp120-induced migration revealed that Pyk2 activates p38 mitogen-activated protein kinase, which in turn activates the F-actin-binding protein, leukocyte-specific protein 1, and enhances its association with actin. Taken together, our studies provide an insight into a novel gp120-mediated pathway that regulates DC chemotaxis and contributes to the dissemination of HIV-1 within an infected person.
authors.affiliation: Department of Pathology, Ohio State University, Columbus, OH 43210, USA.
authors.forename: Appakkudal R
authors.initials: AR
authors.lastname: Anand
authors.forename: Anil
authors.initials: A
authors.lastname: Prasad
authors.forename: Ritu R
authors.initials: RR
authors.lastname: Bradley
authors.forename: Yadwinder S
authors.initials: YS
authors.lastname: Deol
authors.forename: Tirumuru
authors.initials: T
authors.lastname: Nagaraja
authors.forename: Xianghui
authors.initials: X
authors.lastname: Ren
authors.forename: Ernest F
authors.initials: EF
authors.lastname: Terwilliger
authors.forename: Ramesh K
authors.initials: RK
authors.lastname: Ganju
mesh_terms: D015153:Blotting, Western; D002465:Cell Movement; D002633:Chemotaxis; D003713:Dendritic Cells / Q000378:metabolism*; D005434:Flow Cytometry; D051418:Focal Adhesion Kinase 2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008840:Microfilament Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000494:pharmacology; D019713:Receptors, CCR5 / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020032:Tyrphostins / Q000494:pharmacology; D048051:p38 Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism*
chemical_list: D015699:HIV Envelope Protein gp120; C489183:LSP1 protein, human; D008840:Microfilament Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D019713:Receptors, CCR5; D020032:Tyrphostins; C406122:tyrphostin A9; D051418:Focal Adhesion Kinase 2; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: J Leukoc Biol. 2003 Nov;74(5):676-82
references.pmid: 12960231
references.citation: Immunol Res. 2006;35(1-2):65-74
references.pmid: 17003510
references.citation: Blood. 2001 Nov 15;98(10):3022-9
references.pmid: 11698286
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10740-5
references.pmid: 12960403
references.citation: Blood. 2000 Sep 1;96(5):1827-35
references.pmid: 10961883
references.citation: J Virol. 1998 Oct;72(10):7992-8001
references.pmid: 9733838
references.citation: J Exp Med. 2007 Feb 19;204(2):421-30
references.pmid: 17296787
references.citation: Nature. 1995 Aug 31;376(6543):737-45
references.pmid: 7544443
references.citation: J Biol Chem. 1999 Apr 9;274(15):10140-4
references.pmid: 10187797
references.citation: Neuron. 2001 Feb;29(2):485-96
references.pmid: 11239437
references.citation: J Immunol. 1999 Jul 1;163(1):420-6
references.pmid: 10384144
references.citation: Immunology. 1995 Jul;85(3):475-84
references.pmid: 7558138
references.citation: Immunity. 2007 Feb;26(2):257-70
references.pmid: 17306567
references.citation: J Virol. 2004 Sep;78(18):9763-72
references.pmid: 15331709
references.citation: Blood. 2004 Mar 15;103(6):2170-9
references.pmid: 14630806
references.citation: J Immunol. 2005 Apr 1;174(7):4070-80
references.pmid: 15778365
references.citation: J Virol. 2007 May;81(10):5385-94
references.pmid: 17314166
references.citation: J Exp Med. 2000 Aug 21;192(4):587-94
references.pmid: 10952729
references.citation: J Virol. 2006 Dec;80(24):11899-910
references.pmid: 17005662
references.citation: J Immunol. 2004 Dec 15;173(12):7497-505
references.pmid: 15585876
references.citation: J Immunol. 2002 Jul 1;169(1):415-23
references.pmid: 12077272
references.citation: Immunology. 2004 Apr;111(4):407-15
references.pmid: 15056377
references.citation: Immunol Cell Biol. 2002 Oct;80(5):489-96
references.pmid: 12225386
references.citation: J Virol. 2004 May;78(10):5223-32
references.pmid: 15113904
references.citation: J Immunol. 1995 Oct 1;155(7):3563-9
references.pmid: 7561054
references.citation: Hum Gene Ther. 2003 Mar 1;14(4):393-402
references.pmid: 12659680
references.citation: J Biol Chem. 2002 May 17;277(20):18111-7
references.pmid: 11877445
references.citation: J Exp Med. 1997 Nov 17;186(10):1793-8
references.pmid: 9362541
references.citation: J Leukoc Biol. 2001 Mar;69(3):497-504
references.pmid: 11261799
references.citation: Curr HIV/AIDS Rep. 2005 Feb;2(1):10-5
references.pmid: 16091243
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17453-8
references.pmid: 17956986
references.citation: Cell Signal. 2000 Mar;12(3):123-33
references.pmid: 10704819
references.citation: Cancer Immunol Immunother. 2007 Oct;56(10):1615-24
references.pmid: 17356843
references.citation: J Exp Med. 2005 Feb 7;201(3):409-18
references.pmid: 15684321
references.citation: J Immunol. 2004 Aug 1;173(3):2091-8
references.pmid: 15265945
references.citation: J Immunol. 2006 Nov 15;177(10):7103-13
references.pmid: 17082627
references.citation: J Clin Invest. 1999 Aug;104(3):327-35
references.pmid: 10430614
references.citation: J Biol Chem. 2000 Jun 9;275(23):17263-8
references.pmid: 10747947
references.citation: J Leukoc Biol. 2003 Jan;73(1):30-48
references.pmid: 12525560
references.citation: Blood. 2005 Apr 1;105(7):2869-76
references.pmid: 15585656
references.citation: J Biol Chem. 1997 Jan 3;272(1):228-32
references.pmid: 8995252
references.citation: Biochem Biophys Res Commun. 2002 Feb 8;290(5):1470-7
references.pmid: 11820787
references.citation: Blood. 2001 Nov 15;98(10):2909-16
references.pmid: 11698270
references.citation: J Exp Med. 1998 May 18;187(10):1623-31
references.pmid: 9584140
references.citation: Springer Semin Immunopathol. 2000;22(4):345-69
references.pmid: 11155441
references.citation: J Viral Hepat. 2006 Sep;13(9):605-12
references.pmid: 16907847
references.citation: J Virol. 2005 Oct;79(19):12597-601
references.pmid: 16160188
references.citation: J Virol. 2007 Sep;81(17):8933-43
references.pmid: 17567699
references.citation: J Leukoc Biol. 2006 Nov;80(5):994-1000
references.pmid: 16912071